Global Riboflavin Kinase Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Riboflavin Kinase Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 96

Published Date: 06 Aug 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Riboflavin Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Riboflavin Kinase market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Riboflavin Kinase market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Food Additives occupied for % of the Riboflavin Kinase global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Feed Grade segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Riboflavin Kinase include DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals and Hubei Guangji Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Riboflavin Kinase market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Riboflavin Kinase manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Riboflavin Kinase market based on the following parameters – headquarters, production locations, products portfolio, Riboflavin Kinase revenue, sales, average price and gross margin, recent developments.

Evaluation and forecast the Riboflavin Kinase market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Riboflavin Kinase market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
Feed Grade
Food Grade
Pharma Grade

Market segment by Application (2017-2028; USD Million)
Food Additives
Animal Feeding
Pharmaceutical
Health Supplements
Cosmetic And Personal Care
Others

The key market players for global Riboflavin Kinase market are listed below:
DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical

Region Segment (2017-2028; USD Million)
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Riboflavin Kinase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Riboflavin Kinase, with price, sales, revenue and global market share of Riboflavin Kinase from 2019 to 2022.
Chapter 3, the Riboflavin Kinase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Riboflavin Kinase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Riboflavin Kinase market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Riboflavin Kinase.
Chapter 13, 14, and 15, to describe Riboflavin Kinase sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Riboflavin Kinase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Riboflavin Kinase Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Feed Grade
1.2.3 Food Grade
1.2.4 Pharma Grade
1.3 Market Analysis by Application
1.3.1 Overview: Global Riboflavin Kinase Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Food Additives
1.3.3 Animal Feeding
1.3.4 Pharmaceutical
1.3.5 Health Supplements
1.3.6 Cosmetic And Personal Care
1.3.7 Others
1.4 Global Riboflavin Kinase Market Size & Forecast
1.4.1 Global Riboflavin Kinase Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Riboflavin Kinase Sales in Volume (2017-2028)
1.4.3 Global Riboflavin Kinase Price (2017-2028)
1.5 Global Riboflavin Kinase Production Capacity Analysis
1.5.1 Global Riboflavin Kinase Total Production Capacity (2017-2028)
1.5.2 Global Riboflavin Kinase Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Riboflavin Kinase Market Drivers
1.6.2 Riboflavin Kinase Market Restraints
1.6.3 Riboflavin Kinase Trends Analysis

2 Manufacturers Profiles
2.1 DSM
2.1.1 DSM Details
2.1.2 DSM Major Business
2.1.3 DSM Riboflavin Kinase Product and Services
2.1.4 DSM Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BASF
2.2.1 BASF Details
2.2.2 BASF Major Business
2.2.3 BASF Riboflavin Kinase Product and Services
2.2.4 BASF Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 NB Group
2.3.1 NB Group Details
2.3.2 NB Group Major Business
2.3.3 NB Group Riboflavin Kinase Product and Services
2.3.4 NB Group Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shanghai Acebright Pharmaceuticals
2.4.1 Shanghai Acebright Pharmaceuticals Details
2.4.2 Shanghai Acebright Pharmaceuticals Major Business
2.4.3 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Product and Services
2.4.4 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hubei Guangji Pharmaceutical
2.5.1 Hubei Guangji Pharmaceutical Details
2.5.2 Hubei Guangji Pharmaceutical Major Business
2.5.3 Hubei Guangji Pharmaceutical Riboflavin Kinase Product and Services
2.5.4 Hubei Guangji Pharmaceutical Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Ningxia Qiyuan Pharma
2.6.1 Ningxia Qiyuan Pharma Details
2.6.2 Ningxia Qiyuan Pharma Major Business
2.6.3 Ningxia Qiyuan Pharma Riboflavin Kinase Product and Services
2.6.4 Ningxia Qiyuan Pharma Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hebei Shengxue Dacheng
2.7.1 Hebei Shengxue Dacheng Details
2.7.2 Hebei Shengxue Dacheng Major Business
2.7.3 Hebei Shengxue Dacheng Riboflavin Kinase Product and Services
2.7.4 Hebei Shengxue Dacheng Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Xinfa Pharmaceutical
2.8.1 Xinfa Pharmaceutical Details
2.8.2 Xinfa Pharmaceutical Major Business
2.8.3 Xinfa Pharmaceutical Riboflavin Kinase Product and Services
2.8.4 Xinfa Pharmaceutical Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Riboflavin Kinase Breakdown Data by Manufacturer
3.1 Global Riboflavin Kinase Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Riboflavin Kinase Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Riboflavin Kinase
3.4 Market Concentration Rate
3.4.1 Top 3 Riboflavin Kinase Manufacturer Market Share in 2021
3.4.2 Top 6 Riboflavin Kinase Manufacturer Market Share in 2021
3.5 Global Riboflavin Kinase Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Riboflavin Kinase Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Riboflavin Kinase Market Size by Region
4.1.1 Global Riboflavin Kinase Sales in Volume by Region (2017-2028)
4.1.2 Global Riboflavin Kinase Revenue by Region (2017-2028)
4.2 North America Riboflavin Kinase Revenue (2017-2028)
4.3 Europe Riboflavin Kinase Revenue (2017-2028)
4.4 Asia-Pacific Riboflavin Kinase Revenue (2017-2028)
4.5 South America Riboflavin Kinase Revenue (2017-2028)
4.6 Middle East and Africa Riboflavin Kinase Revenue (2017-2028)

5 Market Segment by Type
5.1 Global Riboflavin Kinase Sales in Volume by Type (2017-2028)
5.2 Global Riboflavin Kinase Revenue by Type (2017-2028)
5.3 Global Riboflavin Kinase Price by Type (2017-2028)

6 Market Segment by Application
6.1 Global Riboflavin Kinase Sales in Volume by Application (2017-2028)
6.2 Global Riboflavin Kinase Revenue by Application (2017-2028)
6.3 Global Riboflavin Kinase Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
7.1 North America Riboflavin Kinase Sales by Type (2017-2028)
7.2 North America Riboflavin Kinase Sales by Application (2017-2028)
7.3 North America Riboflavin Kinase Market Size by Country
7.3.1 North America Riboflavin Kinase Sales in Volume by Country (2017-2028)
7.3.2 North America Riboflavin Kinase Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
8.1 Europe Riboflavin Kinase Sales by Type (2017-2028)
8.2 Europe Riboflavin Kinase Sales by Application (2017-2028)
8.3 Europe Riboflavin Kinase Market Size by Country
8.3.1 Europe Riboflavin Kinase Sales in Volume by Country (2017-2028)
8.3.2 Europe Riboflavin Kinase Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Riboflavin Kinase Sales by Type (2017-2028)
9.2 Asia-Pacific Riboflavin Kinase Sales by Application (2017-2028)
9.3 Asia-Pacific Riboflavin Kinase Market Size by Region
9.3.1 Asia-Pacific Riboflavin Kinase Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Riboflavin Kinase Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
10.1 South America Riboflavin Kinase Sales by Type (2017-2028)
10.2 South America Riboflavin Kinase Sales by Application (2017-2028)
10.3 South America Riboflavin Kinase Market Size by Country
10.3.1 South America Riboflavin Kinase Sales in Volume by Country (2017-2028)
10.3.2 South America Riboflavin Kinase Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Riboflavin Kinase Sales by Type (2017-2028)
11.2 Middle East & Africa Riboflavin Kinase Sales by Application (2017-2028)
11.3 Middle East & Africa Riboflavin Kinase Market Size by Country
11.3.1 Middle East & Africa Riboflavin Kinase Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Riboflavin Kinase Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Riboflavin Kinase and Key Manufacturers
12.2 Manufacturing Costs Percentage of Riboflavin Kinase
12.3 Riboflavin Kinase Production Process
12.4 Riboflavin Kinase Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Riboflavin Kinase Typical Distributors
13.3 Riboflavin Kinase Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Riboflavin Kinase Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Riboflavin Kinase Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. DSM Basic Information, Manufacturing Base and Competitors
Table 4. DSM Major Business
Table 5. DSM Riboflavin Kinase Product and Services
Table 6. DSM Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. BASF Basic Information, Manufacturing Base and Competitors
Table 8. BASF Major Business
Table 9. BASF Riboflavin Kinase Product and Services
Table 10. BASF Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. NB Group Basic Information, Manufacturing Base and Competitors
Table 12. NB Group Major Business
Table 13. NB Group Riboflavin Kinase Product and Services
Table 14. NB Group Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shanghai Acebright Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Shanghai Acebright Pharmaceuticals Major Business
Table 17. Shanghai Acebright Pharmaceuticals Riboflavin Kinase Product and Services
Table 18. Shanghai Acebright Pharmaceuticals Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hubei Guangji Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Hubei Guangji Pharmaceutical Major Business
Table 21. Hubei Guangji Pharmaceutical Riboflavin Kinase Product and Services
Table 22. Hubei Guangji Pharmaceutical Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Ningxia Qiyuan Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Ningxia Qiyuan Pharma Major Business
Table 25. Ningxia Qiyuan Pharma Riboflavin Kinase Product and Services
Table 26. Ningxia Qiyuan Pharma Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hebei Shengxue Dacheng Basic Information, Manufacturing Base and Competitors
Table 28. Hebei Shengxue Dacheng Major Business
Table 29. Hebei Shengxue Dacheng Riboflavin Kinase Product and Services
Table 30. Hebei Shengxue Dacheng Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Xinfa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Xinfa Pharmaceutical Major Business
Table 33. Xinfa Pharmaceutical Riboflavin Kinase Product and Services
Table 34. Xinfa Pharmaceutical Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Riboflavin Kinase Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 36. Global Riboflavin Kinase Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Riboflavin Kinase, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Riboflavin Kinase Production Capacity by Company, (Tons): 2020 VS 2021
Table 39. Head Office and Riboflavin Kinase Production Site of Key Manufacturer
Table 40. Riboflavin Kinase New Entrant and Capacity Expansion Plans
Table 41. Riboflavin Kinase Mergers & Acquisitions in the Past Five Years
Table 42. Global Riboflavin Kinase Sales by Region (2017-2022) & (Tons)
Table 43. Global Riboflavin Kinase Sales by Region (2023-2028) & (Tons)
Table 44. Global Riboflavin Kinase Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Riboflavin Kinase Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 47. Global Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 48. Global Riboflavin Kinase Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Riboflavin Kinase Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Riboflavin Kinase Price by Type (2017-2022) & (US$/Ton)
Table 51. Global Riboflavin Kinase Price by Type (2023-2028) & (US$/Ton)
Table 52. Global Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 53. Global Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 54. Global Riboflavin Kinase Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Riboflavin Kinase Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Riboflavin Kinase Price by Application (2017-2022) & (US$/Ton)
Table 57. Global Riboflavin Kinase Price by Application (2023-2028) & (US$/Ton)
Table 58. North America Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 59. North America Riboflavin Kinase Sales by Country (2023-2028) & (Tons)
Table 60. North America Riboflavin Kinase Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Riboflavin Kinase Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 63. North America Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 64. North America Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 65. North America Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 66. Europe Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 67. Europe Riboflavin Kinase Sales by Country (2023-2028) & (Tons)
Table 68. Europe Riboflavin Kinase Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Riboflavin Kinase Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 71. Europe Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 72. Europe Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 73. Europe Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 74. Asia-Pacific Riboflavin Kinase Sales by Region (2017-2022) & (Tons)
Table 75. Asia-Pacific Riboflavin Kinase Sales by Region (2023-2028) & (Tons)
Table 76. Asia-Pacific Riboflavin Kinase Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Riboflavin Kinase Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 79. Asia-Pacific Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 80. Asia-Pacific Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 81. Asia-Pacific Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 82. South America Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 83. South America Riboflavin Kinase Sales by Country (2023-2028) & (Tons)
Table 84. South America Riboflavin Kinase Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Riboflavin Kinase Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 87. South America Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 88. South America Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 89. South America Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 90. Middle East & Africa Riboflavin Kinase Sales by Region (2017-2022) & (Tons)
Table 91. Middle East & Africa Riboflavin Kinase Sales by Region (2023-2028) & (Tons)
Table 92. Middle East & Africa Riboflavin Kinase Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Riboflavin Kinase Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 95. Middle East & Africa Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 96. Middle East & Africa Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 97. Middle East & Africa Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 98. Riboflavin Kinase Raw Material
Table 99. Key Manufacturers of Riboflavin Kinase Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Riboflavin Kinase Typical Distributors
Table 103. Riboflavin Kinase Typical Customers
List of Figures
Figure 1. Riboflavin Kinase Picture
Figure 2. Global Riboflavin Kinase Revenue Market Share by Type in 2021
Figure 3. Feed Grade
Figure 4. Food Grade
Figure 5. Pharma Grade
Figure 6. Global Riboflavin Kinase Revenue Market Share by Application in 2021
Figure 7. Food Additives
Figure 8. Animal Feeding
Figure 9. Pharmaceutical
Figure 10. Health Supplements
Figure 11. Cosmetic And Personal Care
Figure 12. Others
Figure 13. Global Riboflavin Kinase Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 14. Global Riboflavin Kinase Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Riboflavin Kinase Sales (2017-2028) & (Tons)
Figure 16. Global Riboflavin Kinase Price (2017-2028) & (US$/Ton)
Figure 17. Global Riboflavin Kinase Production Capacity (2017-2028) & (Tons)
Figure 18. Global Riboflavin Kinase Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Riboflavin Kinase Market Drivers
Figure 20. Riboflavin Kinase Market Restraints
Figure 21. Riboflavin Kinase Market Trends
Figure 22. Global Riboflavin Kinase Sales Market Share by Manufacturer in 2021
Figure 23. Global Riboflavin Kinase Revenue Market Share by Manufacturer in 2021
Figure 24. Riboflavin Kinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Riboflavin Kinase Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Riboflavin Kinase Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 28. Global Riboflavin Kinase Revenue Market Share by Region (2017-2028)
Figure 29. North America Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 30. Europe Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 32. South America Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 34. Global Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 35. Global Riboflavin Kinase Revenue Market Share by Type (2017-2028)
Figure 36. Global Riboflavin Kinase Price by Type (2017-2028) & (US$/Ton)
Figure 37. Global Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 38. Global Riboflavin Kinase Revenue Market Share by Application (2017-2028)
Figure 39. Global Riboflavin Kinase Price by Application (2017-2028) & (US$/Ton)
Figure 40. North America Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 41. North America Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 42. North America Riboflavin Kinase Sales Market Share by Country (2017-2028)
Figure 43. North America Riboflavin Kinase Revenue Market Share by Country (2017-2028)
Figure 44. United States Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 48. Europe Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 49. Europe Riboflavin Kinase Sales Market Share by Country (2017-2028)
Figure 50. Europe Riboflavin Kinase Revenue Market Share by Country (2017-2028)
Figure 51. Germany Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Riboflavin Kinase Revenue Market Share by Region (2017-2028)
Figure 60. China Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 67. South America Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 68. South America Riboflavin Kinase Sales Market Share by Country (2017-2028)
Figure 69. South America Riboflavin Kinase Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Riboflavin Kinase Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Riboflavin Kinase in 2021
Figure 81. Manufacturing Process Analysis of Riboflavin Kinase
Figure 82. Riboflavin Kinase Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Riboflavin Kinase Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Riboflavin Kinase Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 96

Published Date: 06 Aug 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Riboflavin Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Riboflavin Kinase market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Riboflavin Kinase market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Food Additives occupied for % of the Riboflavin Kinase global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Feed Grade segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Riboflavin Kinase include DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals and Hubei Guangji Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Riboflavin Kinase market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Riboflavin Kinase manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Riboflavin Kinase market based on the following parameters – headquarters, production locations, products portfolio, Riboflavin Kinase revenue, sales, average price and gross margin, recent developments.

Evaluation and forecast the Riboflavin Kinase market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Riboflavin Kinase market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
Feed Grade
Food Grade
Pharma Grade

Market segment by Application (2017-2028; USD Million)
Food Additives
Animal Feeding
Pharmaceutical
Health Supplements
Cosmetic And Personal Care
Others

The key market players for global Riboflavin Kinase market are listed below:
DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical

Region Segment (2017-2028; USD Million)
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Riboflavin Kinase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Riboflavin Kinase, with price, sales, revenue and global market share of Riboflavin Kinase from 2019 to 2022.
Chapter 3, the Riboflavin Kinase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Riboflavin Kinase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Riboflavin Kinase market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Riboflavin Kinase.
Chapter 13, 14, and 15, to describe Riboflavin Kinase sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Riboflavin Kinase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Riboflavin Kinase Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Feed Grade
1.2.3 Food Grade
1.2.4 Pharma Grade
1.3 Market Analysis by Application
1.3.1 Overview: Global Riboflavin Kinase Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Food Additives
1.3.3 Animal Feeding
1.3.4 Pharmaceutical
1.3.5 Health Supplements
1.3.6 Cosmetic And Personal Care
1.3.7 Others
1.4 Global Riboflavin Kinase Market Size & Forecast
1.4.1 Global Riboflavin Kinase Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Riboflavin Kinase Sales in Volume (2017-2028)
1.4.3 Global Riboflavin Kinase Price (2017-2028)
1.5 Global Riboflavin Kinase Production Capacity Analysis
1.5.1 Global Riboflavin Kinase Total Production Capacity (2017-2028)
1.5.2 Global Riboflavin Kinase Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Riboflavin Kinase Market Drivers
1.6.2 Riboflavin Kinase Market Restraints
1.6.3 Riboflavin Kinase Trends Analysis

2 Manufacturers Profiles
2.1 DSM
2.1.1 DSM Details
2.1.2 DSM Major Business
2.1.3 DSM Riboflavin Kinase Product and Services
2.1.4 DSM Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BASF
2.2.1 BASF Details
2.2.2 BASF Major Business
2.2.3 BASF Riboflavin Kinase Product and Services
2.2.4 BASF Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 NB Group
2.3.1 NB Group Details
2.3.2 NB Group Major Business
2.3.3 NB Group Riboflavin Kinase Product and Services
2.3.4 NB Group Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shanghai Acebright Pharmaceuticals
2.4.1 Shanghai Acebright Pharmaceuticals Details
2.4.2 Shanghai Acebright Pharmaceuticals Major Business
2.4.3 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Product and Services
2.4.4 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hubei Guangji Pharmaceutical
2.5.1 Hubei Guangji Pharmaceutical Details
2.5.2 Hubei Guangji Pharmaceutical Major Business
2.5.3 Hubei Guangji Pharmaceutical Riboflavin Kinase Product and Services
2.5.4 Hubei Guangji Pharmaceutical Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Ningxia Qiyuan Pharma
2.6.1 Ningxia Qiyuan Pharma Details
2.6.2 Ningxia Qiyuan Pharma Major Business
2.6.3 Ningxia Qiyuan Pharma Riboflavin Kinase Product and Services
2.6.4 Ningxia Qiyuan Pharma Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hebei Shengxue Dacheng
2.7.1 Hebei Shengxue Dacheng Details
2.7.2 Hebei Shengxue Dacheng Major Business
2.7.3 Hebei Shengxue Dacheng Riboflavin Kinase Product and Services
2.7.4 Hebei Shengxue Dacheng Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Xinfa Pharmaceutical
2.8.1 Xinfa Pharmaceutical Details
2.8.2 Xinfa Pharmaceutical Major Business
2.8.3 Xinfa Pharmaceutical Riboflavin Kinase Product and Services
2.8.4 Xinfa Pharmaceutical Riboflavin Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Riboflavin Kinase Breakdown Data by Manufacturer
3.1 Global Riboflavin Kinase Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Riboflavin Kinase Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Riboflavin Kinase
3.4 Market Concentration Rate
3.4.1 Top 3 Riboflavin Kinase Manufacturer Market Share in 2021
3.4.2 Top 6 Riboflavin Kinase Manufacturer Market Share in 2021
3.5 Global Riboflavin Kinase Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Riboflavin Kinase Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Riboflavin Kinase Market Size by Region
4.1.1 Global Riboflavin Kinase Sales in Volume by Region (2017-2028)
4.1.2 Global Riboflavin Kinase Revenue by Region (2017-2028)
4.2 North America Riboflavin Kinase Revenue (2017-2028)
4.3 Europe Riboflavin Kinase Revenue (2017-2028)
4.4 Asia-Pacific Riboflavin Kinase Revenue (2017-2028)
4.5 South America Riboflavin Kinase Revenue (2017-2028)
4.6 Middle East and Africa Riboflavin Kinase Revenue (2017-2028)

5 Market Segment by Type
5.1 Global Riboflavin Kinase Sales in Volume by Type (2017-2028)
5.2 Global Riboflavin Kinase Revenue by Type (2017-2028)
5.3 Global Riboflavin Kinase Price by Type (2017-2028)

6 Market Segment by Application
6.1 Global Riboflavin Kinase Sales in Volume by Application (2017-2028)
6.2 Global Riboflavin Kinase Revenue by Application (2017-2028)
6.3 Global Riboflavin Kinase Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
7.1 North America Riboflavin Kinase Sales by Type (2017-2028)
7.2 North America Riboflavin Kinase Sales by Application (2017-2028)
7.3 North America Riboflavin Kinase Market Size by Country
7.3.1 North America Riboflavin Kinase Sales in Volume by Country (2017-2028)
7.3.2 North America Riboflavin Kinase Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
8.1 Europe Riboflavin Kinase Sales by Type (2017-2028)
8.2 Europe Riboflavin Kinase Sales by Application (2017-2028)
8.3 Europe Riboflavin Kinase Market Size by Country
8.3.1 Europe Riboflavin Kinase Sales in Volume by Country (2017-2028)
8.3.2 Europe Riboflavin Kinase Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Riboflavin Kinase Sales by Type (2017-2028)
9.2 Asia-Pacific Riboflavin Kinase Sales by Application (2017-2028)
9.3 Asia-Pacific Riboflavin Kinase Market Size by Region
9.3.1 Asia-Pacific Riboflavin Kinase Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Riboflavin Kinase Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
10.1 South America Riboflavin Kinase Sales by Type (2017-2028)
10.2 South America Riboflavin Kinase Sales by Application (2017-2028)
10.3 South America Riboflavin Kinase Market Size by Country
10.3.1 South America Riboflavin Kinase Sales in Volume by Country (2017-2028)
10.3.2 South America Riboflavin Kinase Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Riboflavin Kinase Sales by Type (2017-2028)
11.2 Middle East & Africa Riboflavin Kinase Sales by Application (2017-2028)
11.3 Middle East & Africa Riboflavin Kinase Market Size by Country
11.3.1 Middle East & Africa Riboflavin Kinase Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Riboflavin Kinase Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Riboflavin Kinase and Key Manufacturers
12.2 Manufacturing Costs Percentage of Riboflavin Kinase
12.3 Riboflavin Kinase Production Process
12.4 Riboflavin Kinase Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Riboflavin Kinase Typical Distributors
13.3 Riboflavin Kinase Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Riboflavin Kinase Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Riboflavin Kinase Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. DSM Basic Information, Manufacturing Base and Competitors
Table 4. DSM Major Business
Table 5. DSM Riboflavin Kinase Product and Services
Table 6. DSM Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. BASF Basic Information, Manufacturing Base and Competitors
Table 8. BASF Major Business
Table 9. BASF Riboflavin Kinase Product and Services
Table 10. BASF Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. NB Group Basic Information, Manufacturing Base and Competitors
Table 12. NB Group Major Business
Table 13. NB Group Riboflavin Kinase Product and Services
Table 14. NB Group Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shanghai Acebright Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Shanghai Acebright Pharmaceuticals Major Business
Table 17. Shanghai Acebright Pharmaceuticals Riboflavin Kinase Product and Services
Table 18. Shanghai Acebright Pharmaceuticals Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hubei Guangji Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Hubei Guangji Pharmaceutical Major Business
Table 21. Hubei Guangji Pharmaceutical Riboflavin Kinase Product and Services
Table 22. Hubei Guangji Pharmaceutical Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Ningxia Qiyuan Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Ningxia Qiyuan Pharma Major Business
Table 25. Ningxia Qiyuan Pharma Riboflavin Kinase Product and Services
Table 26. Ningxia Qiyuan Pharma Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hebei Shengxue Dacheng Basic Information, Manufacturing Base and Competitors
Table 28. Hebei Shengxue Dacheng Major Business
Table 29. Hebei Shengxue Dacheng Riboflavin Kinase Product and Services
Table 30. Hebei Shengxue Dacheng Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Xinfa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Xinfa Pharmaceutical Major Business
Table 33. Xinfa Pharmaceutical Riboflavin Kinase Product and Services
Table 34. Xinfa Pharmaceutical Riboflavin Kinase Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Riboflavin Kinase Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 36. Global Riboflavin Kinase Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Riboflavin Kinase, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Riboflavin Kinase Production Capacity by Company, (Tons): 2020 VS 2021
Table 39. Head Office and Riboflavin Kinase Production Site of Key Manufacturer
Table 40. Riboflavin Kinase New Entrant and Capacity Expansion Plans
Table 41. Riboflavin Kinase Mergers & Acquisitions in the Past Five Years
Table 42. Global Riboflavin Kinase Sales by Region (2017-2022) & (Tons)
Table 43. Global Riboflavin Kinase Sales by Region (2023-2028) & (Tons)
Table 44. Global Riboflavin Kinase Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Riboflavin Kinase Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 47. Global Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 48. Global Riboflavin Kinase Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Riboflavin Kinase Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Riboflavin Kinase Price by Type (2017-2022) & (US$/Ton)
Table 51. Global Riboflavin Kinase Price by Type (2023-2028) & (US$/Ton)
Table 52. Global Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 53. Global Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 54. Global Riboflavin Kinase Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Riboflavin Kinase Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Riboflavin Kinase Price by Application (2017-2022) & (US$/Ton)
Table 57. Global Riboflavin Kinase Price by Application (2023-2028) & (US$/Ton)
Table 58. North America Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 59. North America Riboflavin Kinase Sales by Country (2023-2028) & (Tons)
Table 60. North America Riboflavin Kinase Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Riboflavin Kinase Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 63. North America Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 64. North America Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 65. North America Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 66. Europe Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 67. Europe Riboflavin Kinase Sales by Country (2023-2028) & (Tons)
Table 68. Europe Riboflavin Kinase Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Riboflavin Kinase Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 71. Europe Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 72. Europe Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 73. Europe Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 74. Asia-Pacific Riboflavin Kinase Sales by Region (2017-2022) & (Tons)
Table 75. Asia-Pacific Riboflavin Kinase Sales by Region (2023-2028) & (Tons)
Table 76. Asia-Pacific Riboflavin Kinase Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Riboflavin Kinase Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 79. Asia-Pacific Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 80. Asia-Pacific Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 81. Asia-Pacific Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 82. South America Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 83. South America Riboflavin Kinase Sales by Country (2023-2028) & (Tons)
Table 84. South America Riboflavin Kinase Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Riboflavin Kinase Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 87. South America Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 88. South America Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 89. South America Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 90. Middle East & Africa Riboflavin Kinase Sales by Region (2017-2022) & (Tons)
Table 91. Middle East & Africa Riboflavin Kinase Sales by Region (2023-2028) & (Tons)
Table 92. Middle East & Africa Riboflavin Kinase Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Riboflavin Kinase Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 95. Middle East & Africa Riboflavin Kinase Sales by Type (2023-2028) & (Tons)
Table 96. Middle East & Africa Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 97. Middle East & Africa Riboflavin Kinase Sales by Application (2023-2028) & (Tons)
Table 98. Riboflavin Kinase Raw Material
Table 99. Key Manufacturers of Riboflavin Kinase Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Riboflavin Kinase Typical Distributors
Table 103. Riboflavin Kinase Typical Customers
List of Figures
Figure 1. Riboflavin Kinase Picture
Figure 2. Global Riboflavin Kinase Revenue Market Share by Type in 2021
Figure 3. Feed Grade
Figure 4. Food Grade
Figure 5. Pharma Grade
Figure 6. Global Riboflavin Kinase Revenue Market Share by Application in 2021
Figure 7. Food Additives
Figure 8. Animal Feeding
Figure 9. Pharmaceutical
Figure 10. Health Supplements
Figure 11. Cosmetic And Personal Care
Figure 12. Others
Figure 13. Global Riboflavin Kinase Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 14. Global Riboflavin Kinase Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Riboflavin Kinase Sales (2017-2028) & (Tons)
Figure 16. Global Riboflavin Kinase Price (2017-2028) & (US$/Ton)
Figure 17. Global Riboflavin Kinase Production Capacity (2017-2028) & (Tons)
Figure 18. Global Riboflavin Kinase Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Riboflavin Kinase Market Drivers
Figure 20. Riboflavin Kinase Market Restraints
Figure 21. Riboflavin Kinase Market Trends
Figure 22. Global Riboflavin Kinase Sales Market Share by Manufacturer in 2021
Figure 23. Global Riboflavin Kinase Revenue Market Share by Manufacturer in 2021
Figure 24. Riboflavin Kinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Riboflavin Kinase Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Riboflavin Kinase Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 28. Global Riboflavin Kinase Revenue Market Share by Region (2017-2028)
Figure 29. North America Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 30. Europe Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 32. South America Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Riboflavin Kinase Revenue (2017-2028) & (USD Million)
Figure 34. Global Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 35. Global Riboflavin Kinase Revenue Market Share by Type (2017-2028)
Figure 36. Global Riboflavin Kinase Price by Type (2017-2028) & (US$/Ton)
Figure 37. Global Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 38. Global Riboflavin Kinase Revenue Market Share by Application (2017-2028)
Figure 39. Global Riboflavin Kinase Price by Application (2017-2028) & (US$/Ton)
Figure 40. North America Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 41. North America Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 42. North America Riboflavin Kinase Sales Market Share by Country (2017-2028)
Figure 43. North America Riboflavin Kinase Revenue Market Share by Country (2017-2028)
Figure 44. United States Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 48. Europe Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 49. Europe Riboflavin Kinase Sales Market Share by Country (2017-2028)
Figure 50. Europe Riboflavin Kinase Revenue Market Share by Country (2017-2028)
Figure 51. Germany Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Riboflavin Kinase Revenue Market Share by Region (2017-2028)
Figure 60. China Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 67. South America Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 68. South America Riboflavin Kinase Sales Market Share by Country (2017-2028)
Figure 69. South America Riboflavin Kinase Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Riboflavin Kinase Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Riboflavin Kinase Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Riboflavin Kinase Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Riboflavin Kinase Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Riboflavin Kinase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Riboflavin Kinase in 2021
Figure 81. Manufacturing Process Analysis of Riboflavin Kinase
Figure 82. Riboflavin Kinase Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical
jiaGou

Add To Cart

gouMai

Buy Now